Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvate Kinase | 1 | 2022 | 192 | 0.680 |
Why?
|
| Podocytes | 1 | 2022 | 391 | 0.580 |
Why?
|
| Diabetic Nephropathies | 2 | 2022 | 969 | 0.540 |
Why?
|
| Diabetic Angiopathies | 1 | 2021 | 805 | 0.510 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 1118 | 0.500 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2021 | 1497 | 0.490 |
Why?
|
| Insulin Resistance | 5 | 2021 | 3989 | 0.380 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 4423 | 0.380 |
Why?
|
| Insulin | 4 | 2022 | 6601 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 12238 | 0.170 |
Why?
|
| Atherosclerosis | 3 | 2022 | 3425 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 558 | 0.160 |
Why?
|
| Protein Kinase C-delta | 1 | 2017 | 115 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 385 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2021 | 701 | 0.130 |
Why?
|
| Receptors, Prostaglandin E, EP3 Subtype | 1 | 2016 | 23 | 0.130 |
Why?
|
| Hyperplasia | 1 | 2019 | 1144 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 777 | 0.130 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 837 | 0.120 |
Why?
|
| Lipolysis | 1 | 2016 | 211 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1489 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2016 | 370 | 0.110 |
Why?
|
| Kidney Medulla | 1 | 2014 | 169 | 0.110 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 371 | 0.110 |
Why?
|
| Regeneration | 1 | 2022 | 1517 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 770 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2454 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3584 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 2878 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 3504 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 5891 | 0.090 |
Why?
|
| Apoptosis | 2 | 2017 | 9511 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1885 | 0.080 |
Why?
|
| Hypoglycemic Agents | 2 | 2017 | 3109 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18289 | 0.070 |
Why?
|
| Animals | 9 | 2022 | 168731 | 0.070 |
Why?
|
| Lipids | 1 | 2017 | 3315 | 0.070 |
Why?
|
| Metformin | 1 | 2014 | 904 | 0.060 |
Why?
|
| Macrophages | 2 | 2017 | 5772 | 0.060 |
Why?
|
| Mice | 6 | 2022 | 81792 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2021 | 23589 | 0.060 |
Why?
|
| Cytokines | 1 | 2017 | 7424 | 0.050 |
Why?
|
| Inflammation | 2 | 2017 | 10846 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 22321 | 0.040 |
Why?
|
| Phlorhizin | 1 | 2017 | 37 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2017 | 129 | 0.040 |
Why?
|
| Drug Implants | 1 | 2017 | 230 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2012 | 3784 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 1458 | 0.030 |
Why?
|
| Lipoproteins, VLDL | 1 | 2016 | 198 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 417 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2019 | 811 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1774 | 0.030 |
Why?
|
| Water Deprivation | 1 | 2014 | 19 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 2014 | 82 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2022 | 2143 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 1688 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 1936 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2017 | 3585 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 594 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 1746 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 594 | 0.020 |
Why?
|
| Adipocytes | 1 | 2016 | 1193 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 2666 | 0.020 |
Why?
|
| Triglycerides | 1 | 2016 | 2441 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1807 | 0.020 |
Why?
|
| Humans | 3 | 2022 | 765734 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 1999 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4563 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5019 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1530 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2141 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2486 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8102 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 5747 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2017 | 6427 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8279 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14445 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 23704 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7584 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11641 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16706 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18972 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12123 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 13079 | 0.010 |
Why?
|
| Male | 2 | 2019 | 363585 | 0.010 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_